| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2010PLoSO...512351L |
| P356 | DOI | 10.1371/JOURNAL.PONE.0012351 |
| P932 | PMC publication ID | 2925953 |
| P698 | PubMed publication ID | 20808809 |
| P5875 | ResearchGate publication ID | 46108555 |
| P50 | author | Colin L. Masters | Q1108510 |
| James D Stewart | Q51899341 | ||
| Dorothy A Machalek | Q57010925 | ||
| Jeremy M Welton | Q59687286 | ||
| Andrew F. Hill | Q37373772 | ||
| Victoria A. Lawson | Q48088830 | ||
| P2093 | author name string | David E Hoke | |
| Brooke Lumicisi | |||
| Helen M Klemm | |||
| Katrina Gouramanis | |||
| Steven J Collins | |||
| P2860 | cites work | Generating a prion with bacterially expressed recombinant prion protein | Q24626352 |
| Formation of native prions from minimal components in vitro | Q24676353 | ||
| Structure of the Flexible Amino-Terminal Domain of Prion Protein Bound to a Sulfated Glycan | Q27658157 | ||
| Mice devoid of PrP are resistant to scrapie | Q28249108 | ||
| Novel proteinaceous infectious particles cause scrapie | Q29547678 | ||
| Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors | Q33824971 | ||
| Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding | Q34084209 | ||
| A single amino acid alteration in murine PrP dramatically alters TSE incubation time. | Q34159979 | ||
| Chlorate--a potent inhibitor of protein sulfation in intact cells | Q34162808 | ||
| Transmissible spongiform encephalopathies. | Q34289917 | ||
| Synthetic mammalian prions | Q34337663 | ||
| In vitro generation of infectious scrapie prions. | Q34413661 | ||
| Species-dependent differences in cofactor utilization for formation of the protease-resistant prion protein in vitro | Q34491356 | ||
| PrPC has nucleic acid chaperoning properties similar to the nucleocapsid protein of HIV-1. | Q34542858 | ||
| Ex vivo propagation of infectious sheep scrapie agent in heterologous epithelial cells expressing ovine prion protein | Q35053001 | ||
| Human prion proteins with pathogenic mutations share common conformational changes resulting in enhanced binding to glycosaminoglycans | Q35778031 | ||
| A simplified recipe for prions | Q35834405 | ||
| Aggregation and fibrillization of prions in lipid membranes | Q36008637 | ||
| Intraventricular pentosan polysulphate in human prion diseases: an observational study in the UK | Q80921395 | ||
| Unifying electrostatic mechanism for metal cations in receptors and cell signaling | Q81497366 | ||
| Protease-resistant prion protein amplification reconstituted with partially purified substrates and synthetic polyanions. | Q51816912 | ||
| Ionic strength and transition metals control PrPSc protease resistance and conversion-inducing activity. | Q51825374 | ||
| A novel generation of heparan sulfate mimetics for the treatment of prion diseases. | Q51834544 | ||
| Enzymatic detergent treatment protocol that reduces protease-resistant prion protein load and infectivity from surgical-steel monofilaments contaminated with a human-derived prion strain. | Q51899304 | ||
| Familial prion disease mutation alters the secondary structure of recombinant mouse prion protein: implications for the mechanism of prion formation. | Q51986669 | ||
| Cell-free formation of protease-resistant prion protein. | Q53204380 | ||
| The prion protein has DNA strand transfer properties similar to retroviral nucleocapsid protein. | Q54014038 | ||
| Correlative studies support lipid peroxidation is linked to PrPres propagation as an early primary pathogenic event in prion disease | Q57092837 | ||
| Prion Protein Interaction with Glycosaminoglycan Occurs with the Formation of Oligomeric Complexes Stabilized by Cu(II) Bridges | Q59419884 | ||
| Transmission of chronic spongiform encephalopathy with kuru plaques from humans to small rodents | Q66895954 | ||
| Some biological characters of cell lines derived from normal rabbit kidney | Q68577384 | ||
| Heparin-like molecules bind differentially to prion-proteins and change their intracellular metabolic fate | Q72656295 | ||
| PrPc does not mediate internalization of PrPSc but is required at an early stage for de novo prion infection of Rov cells | Q36099038 | ||
| Prion protein NMR structure and familial human spongiform encephalopathies | Q36317308 | ||
| Octapeptide repeat insertions increase the rate of protease-resistant prion protein formation | Q36474016 | ||
| Prions and their partners in crime | Q36628157 | ||
| Unifying electrostatic mechanism for receptor-ligand activity | Q37039730 | ||
| Unifying electrostatic mechanism for phosphates and sulfates in cell signaling | Q37039734 | ||
| Treatment of transmissible spongiform encephalopathy by intraventricular drug infusion in animal models | Q37730189 | ||
| Sulfated glycans stimulate endocytosis of the cellular isoform of the prion protein, PrPC, in cultured cells. | Q38287981 | ||
| Prion-protein-specific aptamer reduces PrPSc formation | Q38363420 | ||
| Immunolocalization of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann-Straussler syndrome, Creutzfeldt-Jakob disease and scrapie | Q39101526 | ||
| Sulfated glycosaminoglycans in amyloid plaques of prion diseases | Q39102794 | ||
| Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein | Q39673524 | ||
| Mouse-adapted sporadic human Creutzfeldt-Jakob disease prions propagate in cell culture | Q39966821 | ||
| A cell line infectible by prion strains from different species | Q40033746 | ||
| Packaging of prions into exosomes is associated with a novel pathway of PrP processing. | Q40163902 | ||
| Heparan sulfate is a cellular receptor for purified infectious prions. | Q40466338 | ||
| The prion protein has RNA binding and chaperoning properties characteristic of nucleocapsid protein NCP7 of HIV-1. | Q40817022 | ||
| Selective effects of sodium chlorate treatment on the sulfation of heparan sulfate | Q40912886 | ||
| Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. | Q41064177 | ||
| Mutant and infectious prion proteins display common biochemical properties in cultured cells. | Q41237869 | ||
| Long term survival in a patient with variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulphate | Q42765732 | ||
| On the mechanism of alpha-helix to beta-sheet transition in the recombinant prion protein. | Q43628182 | ||
| Binding of prion protein to lipid membranes and implications for prion conversion | Q43876629 | ||
| Identification of the heparan sulfate binding sites in the cellular prion protein | Q43908316 | ||
| DNA-induced partial unfolding of prion protein leads to its polymerisation to amyloid | Q44127955 | ||
| Structural changes of the prion protein in lipid membranes leading to aggregation and fibrillization | Q44364889 | ||
| In vitro amplification of protease-resistant prion protein requires free sulfhydryl groups | Q44393768 | ||
| Cellular heparan sulfate participates in the metabolism of prions | Q44519369 | ||
| Binding of prion proteins to lipid membranes | Q44707244 | ||
| Nucleic acid and prion protein interaction produces spherical amyloids which can function in vivo as coats of spongiform encephalopathy agent | Q45144035 | ||
| PrPSc incorporation to cells requires endogenous glycosaminoglycan expression | Q45236630 | ||
| Glycosaminoglycan analysis in brain stems from animals infected with the bovine spongiform encephalopathy agent | Q48098402 | ||
| RNA molecules stimulate prion protein conversion | Q48170423 | ||
| Small, highly structured RNAs participate in the conversion of human recombinant PrP(Sen) to PrP(Res) in vitro | Q48214478 | ||
| Familial mutations and the thermodynamic stability of the recombinant human prion protein | Q48784818 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prion protein family | Q24724413 |
| P304 | page(s) | e12351 | |
| P577 | publication date | 2010-08-23 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Glycosaminoglycan sulphation affects the seeded misfolding of a mutant prion protein | |
| P478 | volume | 5 |
| Q41472168 | Glycosaminoglycan sulfation determines the biochemical properties of prion protein aggregates |
| Q39207578 | Heparan Sulfate and Heparin Promote Faithful Prion Replication in Vitro by Binding to Normal and Abnormal Prion Proteins in Protein Misfolding Cyclic Amplification |
| Q90020281 | Heparan sulfate S-domains and extracellular sulfatases (Sulfs): their possible roles in protein aggregation diseases |
| Q64112497 | In vitro Modeling of Prion Strain Tropism |
| Q35075324 | Insect cell-derived cofactors become fully functional after proteinase K and heat treatment for high-fidelity amplification of glycosylphosphatidylinositol-anchored recombinant scrapie and BSE prion proteins |
| Q28084859 | Legal but lethal: functional protein aggregation at the verge of toxicity |
| Q36080838 | Modulation of Glycosaminoglycans Affects PrPSc Metabolism but Does Not Block PrPSc Uptake. |
| Q37644076 | Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality |
| Q50908801 | Prion Diseases. |
| Q35968334 | Prion subcellular fractionation reveals infectivity spectrum, with a high titre-low PrPres level disparity. |
| Q39236820 | Sulfated glycosaminoglycans in protein aggregation diseases |
| Q57171393 | Sulfonic groups induce formation of filopodia in mesenchymal stem cells |
| Q36332945 | The prion protein preference of sporadic Creutzfeldt-Jakob disease subtypes |
Search more.